MX2007011852A - Derivados de fenil-n-acilo de aminas y aminoacidos, un procedimiento para su preparacion y una composicion farmaceutica y su uso. - Google Patents
Derivados de fenil-n-acilo de aminas y aminoacidos, un procedimiento para su preparacion y una composicion farmaceutica y su uso.Info
- Publication number
- MX2007011852A MX2007011852A MX2007011852A MX2007011852A MX2007011852A MX 2007011852 A MX2007011852 A MX 2007011852A MX 2007011852 A MX2007011852 A MX 2007011852A MX 2007011852 A MX2007011852 A MX 2007011852A MX 2007011852 A MX2007011852 A MX 2007011852A
- Authority
- MX
- Mexico
- Prior art keywords
- hydrogen
- hydroxy group
- general formula
- tyrosine
- further characterized
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 12
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 4
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title abstract 3
- 150000003862 amino acid derivatives Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 17
- 230000000694 effects Effects 0.000 claims abstract 8
- 229940035676 analgesics Drugs 0.000 claims abstract 6
- 239000000730 antalgic agent Substances 0.000 claims abstract 6
- 150000001412 amines Chemical class 0.000 claims abstract 5
- 230000000202 analgesic effect Effects 0.000 claims abstract 5
- 230000001430 anti-depressive effect Effects 0.000 claims abstract 5
- 230000000141 anti-hypoxic effect Effects 0.000 claims abstract 5
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract 5
- 230000000648 anti-parkinson Effects 0.000 claims abstract 5
- 239000000935 antidepressant agent Substances 0.000 claims abstract 5
- 229940005513 antidepressants Drugs 0.000 claims abstract 5
- 239000000939 antiparkinson agent Substances 0.000 claims abstract 5
- 230000000035 biogenic effect Effects 0.000 claims abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 30
- 239000001257 hydrogen Substances 0.000 claims 30
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 25
- -1 phenylacetyl Chemical group 0.000 claims 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 18
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- 125000003277 amino group Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 239000000812 cholinergic antagonist Substances 0.000 claims 4
- 230000002048 spasmolytic effect Effects 0.000 claims 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 claims 3
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- JQPTWLBWTVDKNO-INIZCTEOSA-N (2s)-2-[3-(4-hydroxyphenyl)propanoylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)CCC=1C=CC(O)=CC=1)C1=CC=CC=C1 JQPTWLBWTVDKNO-INIZCTEOSA-N 0.000 claims 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 claims 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 2
- 206010021143 Hypoxia Diseases 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- 208000007101 Muscle Cramp Diseases 0.000 claims 2
- HIUONFHURKCCKW-UHFFFAOYSA-N N-phenethylhydrocinnamide Natural products C=1C=CC=CC=1CCNC(=O)CCC1=CC=CC=C1 HIUONFHURKCCKW-UHFFFAOYSA-N 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 208000005392 Spasm Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 230000007954 hypoxia Effects 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- COMSBNSFYYEQOJ-INIZCTEOSA-N (2s)-3-(4-hydroxyphenyl)-2-[3-(4-hydroxyphenyl)propanoylamino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)CCC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 COMSBNSFYYEQOJ-INIZCTEOSA-N 0.000 claims 1
- PKOVGZQJPDDEJO-INIZCTEOSA-N (2s)-3-phenyl-2-(3-phenylpropanoylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)CCC=1C=CC=CC=1)C1=CC=CC=C1 PKOVGZQJPDDEJO-INIZCTEOSA-N 0.000 claims 1
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 claims 1
- SERBNUYNEAQHNJ-UHFFFAOYSA-N 2-phenyl-n-(2-phenylethyl)acetamide Chemical compound C=1C=CC=CC=1CCNC(=O)CC1=CC=CC=C1 SERBNUYNEAQHNJ-UHFFFAOYSA-N 0.000 claims 1
- GYXQXOGMDKYDFU-UHFFFAOYSA-N 3-(4-hydroxyphenyl)-n-(2-phenylethyl)propanamide Chemical compound C1=CC(O)=CC=C1CCC(=O)NCCC1=CC=CC=C1 GYXQXOGMDKYDFU-UHFFFAOYSA-N 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 206010018634 Gouty Arthritis Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- YYOZRLJNMGEFOY-UHFFFAOYSA-N N-[2-(4-hydroxyphenyl)ethyl]-N-phenylacetamide Chemical compound OC1=CC=C(C=C1)CCN(C(C)=O)C1=CC=CC=C1 YYOZRLJNMGEFOY-UHFFFAOYSA-N 0.000 claims 1
- 125000003047 N-acetyl group Chemical group 0.000 claims 1
- LIIPHJDKZNTNII-HNNXBMFYSA-N N-phenylacetylphenylalanine Chemical compound C([C@@H](C(=O)O)NC(=O)CC=1C=CC=CC=1)C1=CC=CC=C1 LIIPHJDKZNTNII-HNNXBMFYSA-N 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000027089 Parkinsonian disease Diseases 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 206010065016 Post-traumatic pain Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- CBYGLQVAMOUFIE-QFIPXVFZSA-N benzyl (2s)-3-(4-hydroxyphenyl)-2-[(2-phenylacetyl)amino]propanoate Chemical compound C1=CC(O)=CC=C1C[C@@H](C(=O)OCC=1C=CC=CC=1)NC(=O)CC1=CC=CC=C1 CBYGLQVAMOUFIE-QFIPXVFZSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 230000003412 degenerative effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002996 emotional effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 210000001503 joint Anatomy 0.000 claims 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- VNVRBDDZSYIUJK-INIZCTEOSA-N methyl (2s)-3-(4-hydroxyphenyl)-2-[(2-phenylacetyl)amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)CC=1C=CC=CC=1)C1=CC=C(O)C=C1 VNVRBDDZSYIUJK-INIZCTEOSA-N 0.000 claims 1
- ITMGOEJLSLAEDI-KRWDZBQOSA-N methyl (2s)-3-phenyl-2-(3-phenylpropanoylamino)propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)CCC=1C=CC=CC=1)C1=CC=CC=C1 ITMGOEJLSLAEDI-KRWDZBQOSA-N 0.000 claims 1
- OCGCFGFKKQLWOK-INIZCTEOSA-N methyl (2s)-3-phenyl-2-[(2-phenylacetyl)amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)CC=1C=CC=CC=1)C1=CC=CC=C1 OCGCFGFKKQLWOK-INIZCTEOSA-N 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 201000003068 rheumatic fever Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002027 skeletal muscle Anatomy 0.000 claims 1
- 201000005671 spondyloarthropathy Diseases 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 201000005060 thrombophlebitis Diseases 0.000 claims 1
- 150000003668 tyrosines Chemical class 0.000 claims 1
- 238000001723 curing Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2005108492/04A RU2309144C2 (ru) | 2005-03-25 | 2005-03-25 | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
| PCT/RU2006/000139 WO2006101422A1 (fr) | 2005-03-25 | 2006-03-24 | Derives n-acyles d'amines et d'acides amines amines contenant des phenyles, procede de fabrication, composition pharmaceutique et son utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007011852A true MX2007011852A (es) | 2008-02-21 |
Family
ID=37024023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007011852A MX2007011852A (es) | 2005-03-25 | 2006-03-24 | Derivados de fenil-n-acilo de aminas y aminoacidos, un procedimiento para su preparacion y una composicion farmaceutica y su uso. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8309766B2 (enExample) |
| EP (1) | EP1876169B1 (enExample) |
| JP (1) | JP5384096B2 (enExample) |
| KR (1) | KR101383580B1 (enExample) |
| CN (1) | CN101180267B (enExample) |
| CA (1) | CA2602545C (enExample) |
| CY (1) | CY1117449T1 (enExample) |
| DK (1) | DK1876169T3 (enExample) |
| EA (1) | EA013644B1 (enExample) |
| ES (1) | ES2564238T3 (enExample) |
| HU (1) | HUE027009T2 (enExample) |
| MX (1) | MX2007011852A (enExample) |
| PL (1) | PL1876169T3 (enExample) |
| PT (1) | PT1876169E (enExample) |
| RU (1) | RU2309144C2 (enExample) |
| SI (1) | SI1876169T1 (enExample) |
| UA (1) | UA88688C2 (enExample) |
| WO (1) | WO2006101422A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642290B2 (en) | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| US7674829B2 (en) | 2004-03-26 | 2010-03-09 | Novaremed Limited | Compounds for the treatment of AIDS and other viral diseases |
| GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| WO2009132978A1 (en) * | 2008-04-29 | 2009-11-05 | F. Hoffmann-La Roche Ag | 4-dimethylaminobutyric acid derivatives |
| WO2011030205A1 (en) * | 2009-09-09 | 2011-03-17 | Novaremed Ltd. | N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation |
| US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| CN103221383B (zh) * | 2010-08-27 | 2016-04-20 | 株式会社新药 | 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物 |
| GB201116335D0 (en) * | 2011-09-21 | 2011-11-02 | Novaremed Ltd | A method of treating or preventing affective disorders |
| ES2578377B1 (es) * | 2014-12-22 | 2017-05-04 | Consejo Superior De Investigaciones Científicas (Csic) | Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos. |
| RU2690188C2 (ru) * | 2017-05-26 | 2019-05-31 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый мультитаргетный препарат для лечения заболеваний у млекопитающих |
| JP2021509398A (ja) * | 2017-08-21 | 2021-03-25 | プレックス ファーマスーティカルズ，インク | 二重作用ｆｋｂｐ１２およびｆｋｂｐ５２阻害剤 |
| RU2678563C1 (ru) * | 2017-10-27 | 2019-01-30 | Михаил Владимирович Овчинников | Водорастворимые производные тирозина, обладающие анальгетическим, противовоспалительным и противоотечным действием |
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
| RU2727703C2 (ru) * | 2018-10-29 | 2020-07-23 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый способ получения (S)-2-(2-(4-гидроксифенил)ацетамидо)-3-фенилпропановой кислоты |
| RU2716258C1 (ru) * | 2019-07-30 | 2020-03-11 | Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий | Пептидный антагонист нмда-рецептора |
| CN117886714A (zh) * | 2024-01-16 | 2024-04-16 | 中国药科大学 | 丙氨酸衍生物、其制备方法及医药用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2711656A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Neue pyridin-3-ole |
| DE2861593D1 (en) * | 1977-06-29 | 1982-03-11 | Beecham Group Plc | Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides |
| JPS57145891A (en) * | 1981-03-05 | 1982-09-09 | Sagami Chem Res Center | Optically active diphosphine ligand |
| JPS57193437A (en) | 1981-05-21 | 1982-11-27 | Ajinomoto Co Inc | Amino acid derivative |
| ES8607214A1 (es) * | 1985-10-16 | 1986-06-01 | Gema Sa | Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos |
| USRE37160E1 (en) * | 1990-06-12 | 2001-05-01 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
| US5403851A (en) * | 1994-04-05 | 1995-04-04 | Interneuron Pharmaceuticals, Inc. | Substituted tryptamines, phenalkylamines and related compounds |
| AU1463997A (en) * | 1995-12-22 | 1997-07-17 | Acea Pharmaceuticals, Inc. | Subtype-selective nmda receptor ligands and the use thereof |
| US6319492B1 (en) * | 1996-11-27 | 2001-11-20 | Rutgers, The State University | Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
| US5912225A (en) * | 1997-04-14 | 1999-06-15 | Johns Hopkins Univ. School Of Medicine | Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
| JPH11127894A (ja) * | 1997-10-30 | 1999-05-18 | Ono Pharmaceut Co Ltd | カルボキシペプチダーゼａ活性測定方法および測定用キット |
| RU2123041C1 (ru) * | 1998-04-02 | 1998-12-10 | Пипия Гулади Эрастович | Бальзам "саратовский" |
| AU761458B2 (en) * | 1998-04-13 | 2003-06-05 | Rutgers, The State University | The construction of copolymer libraries |
| WO1999055330A1 (en) * | 1998-04-27 | 1999-11-04 | Smithkline Beecham Corporation | Ccr-3 receptor antagonists |
| US6414173B1 (en) * | 1998-07-02 | 2002-07-02 | University Of Maryland | Hypervalent silane and siloxane derivatives and the use thereof |
| DE60116200T2 (de) * | 2000-03-09 | 2006-08-17 | Tokuyama Corp., Shunan | Verfahren zur lagerung quaternärer ammonium-salze |
| HUP0303085A2 (hu) * | 2000-09-27 | 2003-12-29 | The Procter & Gamble Co. | Melanokortin receptor ligandumok és ezeket tartalmazó gyógyszerkészítmények |
| US7642290B2 (en) * | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| RU2233289C2 (ru) | 2002-11-04 | 2004-07-27 | Институт органического синтеза Уральского отделения РАН | Способ получения дипептидов |
-
2005
- 2005-03-25 RU RU2005108492/04A patent/RU2309144C2/ru active
-
2006
- 2006-03-24 MX MX2007011852A patent/MX2007011852A/es active IP Right Grant
- 2006-03-24 KR KR1020077024641A patent/KR101383580B1/ko not_active Expired - Fee Related
- 2006-03-24 ES ES06733250.2T patent/ES2564238T3/es not_active Expired - Lifetime
- 2006-03-24 CN CN200680017304.2A patent/CN101180267B/zh not_active Expired - Fee Related
- 2006-03-24 PT PT67332502T patent/PT1876169E/pt unknown
- 2006-03-24 EA EA200702072A patent/EA013644B1/ru not_active IP Right Cessation
- 2006-03-24 US US11/886,965 patent/US8309766B2/en not_active Expired - Fee Related
- 2006-03-24 HU HUE06733250A patent/HUE027009T2/en unknown
- 2006-03-24 SI SI200632027A patent/SI1876169T1/sl unknown
- 2006-03-24 JP JP2008502938A patent/JP5384096B2/ja not_active Expired - Fee Related
- 2006-03-24 WO PCT/RU2006/000139 patent/WO2006101422A1/ru not_active Ceased
- 2006-03-24 UA UAA200711752A patent/UA88688C2/ru unknown
- 2006-03-24 CA CA2602545A patent/CA2602545C/en not_active Expired - Fee Related
- 2006-03-24 DK DK06733250.2T patent/DK1876169T3/en active
- 2006-03-24 EP EP06733250.2A patent/EP1876169B1/en not_active Expired - Lifetime
- 2006-03-24 PL PL06733250T patent/PL1876169T3/pl unknown
-
2012
- 2012-11-12 US US13/674,339 patent/US8546612B2/en not_active Expired - Fee Related
-
2016
- 2016-03-10 CY CY20161100208T patent/CY1117449T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2602545C (en) | 2014-08-19 |
| DK1876169T3 (en) | 2016-03-07 |
| CA2602545A1 (en) | 2006-09-28 |
| US8546612B2 (en) | 2013-10-01 |
| ES2564238T3 (es) | 2016-03-21 |
| EA013644B1 (ru) | 2010-06-30 |
| WO2006101422A1 (fr) | 2006-09-28 |
| CN101180267B (zh) | 2015-06-17 |
| EA200702072A1 (ru) | 2008-02-28 |
| KR101383580B1 (ko) | 2014-04-09 |
| CY1117449T1 (el) | 2017-04-26 |
| RU2309144C2 (ru) | 2007-10-27 |
| SI1876169T1 (sl) | 2016-05-31 |
| JP5384096B2 (ja) | 2014-01-08 |
| US20090111874A1 (en) | 2009-04-30 |
| UA88688C2 (ru) | 2009-11-10 |
| CN101180267A (zh) | 2008-05-14 |
| EP1876169A1 (en) | 2008-01-09 |
| EP1876169B1 (en) | 2015-12-30 |
| PL1876169T3 (pl) | 2016-06-30 |
| HUE027009T2 (en) | 2016-10-28 |
| US20130109880A1 (en) | 2013-05-02 |
| HK1118798A1 (en) | 2009-02-20 |
| KR20080008345A (ko) | 2008-01-23 |
| JP2008534495A (ja) | 2008-08-28 |
| US8309766B2 (en) | 2012-11-13 |
| PT1876169E (pt) | 2016-03-21 |
| EP1876169A4 (en) | 2009-11-04 |
| RU2005108492A (ru) | 2006-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3231043B2 (ja) | 薬理活性を有する硝酸エステルおよびその製法 | |
| CA2173582C (en) | Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation | |
| CA2740087C (en) | Gaba conjugates and methods of use thereof | |
| TW425382B (en) | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | |
| JPH09512798A (ja) | 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物 | |
| TWI630194B (zh) | 雙環止痛化合物 | |
| JP2008534495A5 (enExample) | ||
| US11365177B2 (en) | Chemical uncouplers of respiration and methods of use thereof | |
| CA2044736A1 (fr) | Derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| PL211429B1 (pl) | Zastosowanie medyczne omega-aminoalkiloamidów kwasów R-2-arylo-propionowych oraz nowa klasa omega -R-2-aminoalkiloamidów kwasów R-2-arylo-propionowych i sposób ich wytwarzania | |
| EP3210964A1 (en) | Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate | |
| CN101500982A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性双氯芬酸前药 | |
| EP2049482B1 (en) | Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate | |
| JPH11509540A (ja) | アミジン誘導体とシクロオキシゲナーゼ阻害剤との塩、その製造方法、医薬としての応用及びそれを含有する製薬組成物 | |
| ES2564238T3 (es) | Derivados de aminoácidos y de N-acil aminas que contienen fenilo, métodos para la producción de los mismos, una composición farmacéutica y uso de los mismos | |
| JP2000336063A (ja) | 新規化合物およびその医薬用途 | |
| GB2206347A (en) | Thiourea derivatives | |
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| SG185642A1 (en) | Diclofenac salt of tramadol | |
| ITFI20100001A1 (it) | Composti ad efficacia sia analgesica che antiperalgesica. | |
| CN1729160B (zh) | 治疗慢性痛的药物 | |
| Naser et al. | Synthesis and preliminary pharmacological evaluation of new analogues of diclofenac as potential anti-inflammatory agents | |
| WO2015046405A1 (ja) | 鎮痛剤 | |
| JP2002528387A (ja) | 脂肪酸誘導体 | |
| Selim et al. | Ibuprofen amino acid derivatives: synthesis, docking and biological studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |